Families who have been through a hospice enrollment describe the same experience: a folder of paperwork signed at a kitchen table during the worst week of someone’s life, and a bill months later for a medication everyone assumed was covered. A Medicare rule finalized this week is aimed squarely at that second part.
The document families were never told to ask for
The document at issue is the hospice election statement addendum. It is a written list, specific to the individual patient, of the conditions, items, services and drugs the hospice has determined are not related to the terminal illness and related conditions — and therefore will not be covered under the Medicare hospice benefit.
That list is where the money is. Once someone elects hospice, Medicare pays the hospice a per-diem rate to manage the terminal illness. Anything the hospice classifies as unrelated falls outside that arrangement, and the cost can land on the family or route through other parts of Medicare. A long-standing blood pressure medication, a diabetes drug, an oxygen concentrator — the classification decision determines who pays.
The addendum requirement was created in the FY2020 hospice rule. But it was written so that hospices had to provide it only on request, which meant the protection reached exactly the families who already knew enough to ask for it.
Free retirement updates: Refunds, consumer protections, and benefit deadlines are useful only when people know they exist. The free Retirement Shield newsletter tracks the legitimate ones. Join free.
CMS says the on-request design cost families money
What makes this rule unusual is that the agency named the household consequence itself rather than describing the change in administrative terms. In the final rule issued July 30, 2026, CMS wrote that beneficiaries “may not realize the importance of asking for the addendum and may continue to bear more financial burden as a result.”
The fix is stated just as directly. CMS “made the addendum mandatory for all those electing hospice and not just those who request the addendum,” a change the agency says ensures greater transparency into non-covered items, services and drugs — “potentially leading to a decrease in beneficiary out-of-pocket costs.”
Agencies rarely concede that their own prior design shifted costs onto patients. Here CMS effectively did, and reversed it.
What changes at the kitchen table
The practical difference is the difference between a right and a document. Under the old design, a family had to know the addendum existed, know its name, and know to request it — during an enrollment conversation that is emotionally overwhelming and often conducted under time pressure.
Under the new rule, the list arrives as part of electing hospice. That converts an obscure entitlement into a piece of paper someone is holding, which is what makes it usable. A family with the list in hand can do three things they otherwise could not: see which specific medications have been classified as unrelated before the first bill arrives, question a classification they believe is wrong, and price out the alternatives while there is still time to plan.
Disagreement is the point worth underlining. A hospice’s determination that a drug is unrelated to the terminal illness is a clinical judgment, not an unappealable fact, and families can raise it with the hospice and pursue Medicare’s appeal channels. That conversation is only possible if the determination is visible.
The rest of the rule, briefly
The same final rule carries the FY2027 payment update for hospices: a 2.3 percent increase, reflecting a 3.2 percent market basket increase reduced by a 0.9 percentage point productivity adjustment, worth roughly $755 million in aggregate. The hospice aggregate cap rises to $36,174.75 for FY2027, from $35,361.44.
Hospices that fail to meet quality reporting requirements take a four-percentage-point reduction, leaving them with a 1.7 percent cut instead of the 2.3 percent increase. Noncompliance has run between roughly 20 and 24 percent in recent years, which is a meaningful share of providers. CMS also indicated that a quality indicator would not appear on Care Compare earlier than FY2028.
Those payment provisions take effect with fiscal year 2027, which begins October 1, 2026 — they are not in force today. The rule text and official status are posted in the Federal Register.
What a family should do now
For anyone facing a hospice election in the coming months, the addendum is now something to expect rather than request — but expecting it is not the same as reading it. The list should be reviewed line by line against the patient’s current medication list, and any drug the family believes is connected to the terminal condition should be raised immediately rather than after a bill.
For families already in hospice today, the right to request the addendum has existed since FY2020 and still does. Asking for it is a reasonable, routine request, and a hospice that resists producing it is telling a family something worth hearing.
This article was produced with AI assistance and reviewed by a human editor. Figures are linked to their primary sources; where a claim could not be verified from the public record, we say so.
More Financial Reading
